Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.
about
New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisonsIntensity of Left Atrial Spontaneous Echo Contrast as a Correlate for Stroke Risk Stratification in Patients with Nonvalvular Atrial FibrillationUntreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment optionsImpact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.The use of cardiac magnetic resonance imaging in the diagnostic workup and treatment of atrial fibrillation.Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risksBody mass index and risk of left atrial thrombus in patients with atrial fibrillation.The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study.A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin?Stroke and bleeding risk in atrial fibrillation.Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.Moving the tipping point: the decision to anticoagulate patients with atrial fibrillationChallenges in the classification of atrial fibrillation.Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trialAssociation of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillationA cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol.Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.CHADS(2) score is predictive of left atrial thrombus on precardioversion transesophageal echocardiography in atrial fibrillation.Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillationA Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial FibrillationAssociation of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS)Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives.Choices in the use of ICD-9 codes to identify stroke risk factors can affect the apparent population-level risk factor prevalence and distribution of CHADS2 scoresStroke prevention in atrial fibrillation: understanding the new oral anticoagulants dabigatran, rivaroxaban, and apixabanImpact of CHADS(2) Score on Neurological Severity and Long-Term Outcome in Atrial Fibrillation-Related Ischemic Stroke.A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk scoreUse of anticoagulants in elderly patients: practical recommendationsImpact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.The net clinical benefit of warfarin anticoagulation in atrial fibrillation.Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?Stroke And Bleeding Risk Assessment: Where Are We Now?Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options.Solutions to Reduce Cardiovascular Events in Patients with Atrial Fibrillation.Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.Guideline adherence in antithrombotic treatment after concomitant ablation surgery in atrial fibrillation patients.
P2860
Q21132464-DCC0299E-72BA-4564-BE38-F93A50C95DB9Q27342869-6365375F-FB61-4CCA-9D23-FA7E5E65C8B6Q28081837-C630F96C-942A-479D-937E-D7991E6B74D0Q30371014-56E7FE6E-24C9-405F-AF9C-575A1FE49C72Q30459988-7CE0676A-D7AD-4F43-A0CD-1A4BD96F7F3BQ33572430-68B739AF-1E2C-4A16-ACC5-A34DDEB1031DQ33949244-BA367160-10AE-4F08-B0AA-0E2E6CB0D6B4Q33951474-C203709B-5DAC-4300-9DA2-28688A6CC81EQ34008166-D57BAB68-6028-461C-87A9-523281926E8FQ34146593-FF944887-091B-4929-B3D9-62CA7A07A781Q34200483-F2BE03D6-75A1-4B77-A706-3A10D25E6C38Q34223524-AE99BF5C-E5D2-4C0B-A608-F7B0FE9C5FF9Q34269633-E48D3C80-AB97-4DE1-9975-738A4FB07A87Q34540479-00C53435-5345-4275-BA93-8F7B84A9F35FQ34668483-41CA60E1-9716-4CFF-B285-37063C1DA1D1Q34677974-E4527F50-DACD-4FEE-98CC-269639D9D3F9Q34774724-76A52B2A-8C32-407D-B43F-A1D91D1BA68DQ35062723-9697EF0E-7C63-4073-8199-795199A4BF92Q35071894-28474AF9-564C-407B-962A-D9ADD763CB21Q35089113-96C5442D-C43E-402C-94A8-0CB9D693A2C5Q35639707-ED143051-C3C4-4C3B-8792-D0D0F09012A1Q35660120-C3814AC2-4165-4932-AE5F-4D0C80A7E797Q35752573-71391BD8-383F-4759-A9FF-BEAA02CE126BQ35846377-A9A39C14-6126-4B8E-8FA7-AFCE104851A2Q35879764-571D4CB0-B540-4D74-BEF4-0E9C4F371F9EQ35891480-3A737086-E7F0-4D0C-B764-E19CC25298D0Q36066774-A5539644-C261-447D-BEBC-24BBE7346860Q36190269-40C14720-EC2E-4C1B-A37C-5D216D49FFC4Q36241389-D171F87A-BB35-4C32-B1B9-0D83D4AFF25BQ36518566-C6B0C7E4-2ED3-49EB-86E7-F5F4B9863BA9Q36974348-6553AECA-0971-4702-8B33-244BA332C148Q37199934-24F1DDC4-EA33-407E-87FB-991BB9E06BBCQ37322244-E0666A03-8891-4EB7-BAA9-4E02AE0F2F71Q37421352-38D39510-48A9-49CF-BEF9-DB0BEE405F18Q37442492-653977A4-A603-48D1-9DB3-28172D7B5172Q37469069-24EB6485-77E9-40A9-8BE6-CD03E594D874Q37495633-0C4E72FE-2CF6-4456-85C5-A5FDE485CAD1Q37496280-9DEE8588-F40F-4E70-88B0-E01FE4E24F2CQ37521378-34ABAB03-1145-4AA0-9F92-FB7FF3AB60E6Q37595026-EC6C7A55-608A-4FF5-B04C-3161FDB6ACF8
P2860
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Comparison of risk stratificat ...... nvalvular atrial fibrillation.
@ast
Comparison of risk stratificat ...... nvalvular atrial fibrillation.
@en
type
label
Comparison of risk stratificat ...... nvalvular atrial fibrillation.
@ast
Comparison of risk stratificat ...... nvalvular atrial fibrillation.
@en
prefLabel
Comparison of risk stratificat ...... nvalvular atrial fibrillation.
@ast
Comparison of risk stratificat ...... nvalvular atrial fibrillation.
@en
P2093
P2860
P1476
Comparison of risk stratificat ...... nvalvular atrial fibrillation.
@en
P2093
ATRIA Study Group
Daniel E Singer
Leila Borowsky
Margaret C Fang
Niela K Pomernacki
Yuchiao Chang
P2860
P304
P356
10.1016/J.JACC.2007.09.065
P407
P577
2008-02-01T00:00:00Z